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INTRODUCTION
Craniofacial muscle, comprised of branchiomeric (branchial arch
muscle) and extraocular muscle, has distinct origins and
developmental regulatory mechanisms from that of the trunk
muscle. For example, Wnt signaling has been shown to promote
trunk skeletal muscle differentiation, while inhibiting craniofacial
muscle development (Tzahor et al., 2003). Moreover, investigation
of transcriptional regulation of Myf5, one of the four muscle
regulatory factors (MRFs), revealed separable elements controlling
Myf5 expression in trunk and craniofacial muscle (Carvajal et al.,
2001; Hadchouel et al., 2003). Mrf4 (Myf6 – Mouse Genome
Informatics), another MRF, appears to be dispensable for head
muscle development but is crucial in trunk muscle (Kassar-
Duchossoy et al., 2004). The paired domain factors, Pax3 and Pax7,
have important functions in trunk muscle development but are not
expressed in head muscle (Tajbakhsh et al., 1997).
Classically, two sources have been shown to contribute to
branchiomeric and ocular muscle, cranial paraxial mesoderm (CPM)
and the prechordal plate mesoderm (Noden and Francis-West, 2006;
Chai and Maxson, 2006). Recent work has revealed overlap in the
progenitors that contribute to branchiomeric and cardiac muscle. For
example, lineage tracing in mouse embryos revealed the existence
of the second cardiac lineage, derived from splanchnic mesoderm,
that contributes to both cardiac and branchiomeric muscle
(Buckingham et al., 2005). Fate-mapping studies in mouse and chick
embryos revealed that CPM, in addition to branchiomeric muscle,
also contributes to the cardiac outflow tract (OFT) (Tirosh-Finkel et
al., 2006; Trainor et al., 1994). The significance of separate precursor
populations, with distinct developmental histories, in branchiomeric
muscle development is unknown.
Heterotopic grafting experiments in mouse embryos revealed
substantial plasticity in the CPM, as transplanted CPM was
competent to assume the characteristics of the recipient site (Trainor
et al., 1994; von Scheven et al., 2006a). This observation is
consistent with the demonstration that environmental cues are
crucial for the normal diversification of CPM. Bmp4 was shown to
promote cardiac differentiation and inhibit skeletal muscle
differentiation (Tirosh-Finkel et al., 2006). Similarly, Fgf8 was
shown to promote branchiomeric muscle development while
inhibiting extraocular muscle (EOM) development (von Scheven et
al., 2006a). These findings indicate that signaling from surrounding
tissues determines the fate of progenitor cells within the CPM.
Less is known about the cell-autonomous mechanisms regulating
branchiomeric muscle development. Tbx1 has been shown to be
required for branchiomeric muscle and cardiac OFT development.
In the OFT, Tbx1 regulates proliferation of progenitor cells by
regulating expression of Fgf ligands (Vitelli et al., 2002; Xu et
al., 2004). A similar mechanism may underlie Tbx1-mediated
regulation of branchiomeric muscle development (Kelly et al.,
2004). Capsulin and MyoR (Tcf21 and Msc, respectively – Mouse
Genome Informatics), two basic helix-loop-helix (bHLH)
transcription factors that mark undifferentiated progenitor cells, are
necessary for branchiomeric muscle development (Lu et al., 2002;
von Scheven et al., 2006b). Mice that are double mutant for MyoR
and capsulin lack a subset of first branchial arch-derived muscles,
such as the temporalis, masseter and pterygoids. MyoR and capsulin
probably function as survival factors in differentiating head muscle,
although there may also be a migration defect in MyoR; capsulin
mutants.
Pitx2 is a paired-related homeobox gene mutated in Rieger
syndrome type I, an autosomal dominant, haploinsufficient disorder
that includes tooth anomalies, anterior segment eye defects and
facial dysmorphologies as cardinal features (Diehl et al., 2006; Gage
et al., 1999; Kitamura et al., 1999; Lin et al., 1999; Lu et al., 1999;
Semina et al., 1996). Pitx2 also plays an essential role in the late
aspects of left right asymmetry (LRA) and cardiac OFT
development (Ai et al., 2006; Kioussi et al., 2002). Recent work has
shown that the Pitx2 OFT phenotype can be traced to a defect in
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cardiac cells derived from the second cardiac lineage (Ai et al.,
2006). In this work, we investigated the role of Pitx2 in
branchiomeric muscle.
Our data uncover an evolutionarily conserved role for Pitx2 in
growth and survival of branchiomeric muscle progenitors. Both
conditional ablation of Pitx2 in mouse embryos and manipulation of
Pitx2 dose in chick embryo primary cultures reveal an autonomous
Pitx2 function in branchiomeric muscle precursors. Our findings also
show that MyoR fails to be expressed in Pitx2 mutants, indicating a
defect in undifferentiated muscle progenitors. Expression of Tbx1 is
preserved in Pitx2 mutant embryos suggesting that the Pitx2 and
Tbx1-mediated genetic pathways in branchiomeric muscle are
distinct. Taken together, our data reveal a crucial role for Pitx2 in
branchiomeric muscle development and reveal a branching of genetic
pathways upstream of the MRFs in branchiomeric muscle.
MATERIALS AND METHODS
Mouse alleles used in this study
The Pitx2flox, Pitx2null and Pitx2hypo alleles have been described. Briefly, the
Pitx2flox allele contains LoxP sites flanking Pitx2 exon5 and has been shown
to be a true conditional null allele (Gage et al., 1999). The Pitx2null allele is
a 4 kb deletion that removes Pitx2 exons 5 and 6 and the intervening intron
(Lu et al., 1999). The Pitx2hypo allele is a weak hypomorphic allele,
previously called Pitx2 ab, that contains a deletion of the Pitx2a and Pitx2b
isoforms and has reduced Pitx2c function (Liu et al., 2001). The -catenin
conditional null allele has been described (Brault et al., 2001).
Immunohistochemistry
Embryos were fixed, dehydrated and embedded in paraffin blocks and
sectioned at 5 m. The slides were deparaffinized and rehydrated according
to standard protocols. Antigen retrieval was performed by heating the slides
in a 95°C water bath for 30 minutes in 0.01 mol/l sodium citrate (pH 6.0)
followed by slowly cooling down to room temperature. Sections were
blocked in 3% H2O2 in methanol for 10 minutes at room temperature. The
primary antibody used was mouse anti-chicken polyclonal antibody (from
Developmental Studies Hybridoma Bank, The University of Iowa) diluted
in 1:100 and incubated overnight. The Zymed Histostain-Plus kit was used
according to the manufacturer’s protocol.
Whole-mount LacZ staining and section
After dissection, the embryos were fixed in the fresh-made fixing buffer (0.2
glutaraldehyde, 2% formalin, 5 mmol/l EGTA, 2 mmol/l MgCl2, in 0.1 mol/l
Na2HPO4 pH 7.3) for 20-30 minutes. Following three washes with the rinse
buffer (0.1% sodium deoxycholate, 0.2% NP40, 2 mmol/l MgCl2, in 0.1
mol/l NaH2PO4 pH 7.3), the samples were stained with the staining buffer
(1 mg/ml X-gal, 5 mmol/l potassium ferricyanide, 5 mmol/l potassium
ferrocyanide, in rinse buffer) until the optimized results appeared. After
removing the staining, the embryos were then rinsed with 1 PBS for 5
minutes. All the above procedures were performed at room temperature. The
embryos were finally post-fixed with 10% formalin and could be stored in
this buffer at 4°C. The LacZ-stained embryos were dehydrated in ethanol
and isopropanol, embedded in paraffin blocks and sectioned at 10 m.
Whole-mount and section in situ hybridization
Whole-mount in situ hybridization was performed as previously described
(Lu et al., 1999). The mouse Pitx2 probe was an exon6 fragment that
hybridizes to all Pitx2 isoforms. The myogenin, MyoD, Tbx1 and MyoR
probes have been previously described (Kelly et al., 2004). In situ
hybridization to whole chick embryos was carried out as described by
Francis-West et al. (Francis-West et al., 1995). 35S-in situ hybridization to
tissue sections was performed on 7 m wax sections as described (Francis-
West et al., 1994). The Pitx2 probe is described by Yu et al. (Yu et al., 2001)
and the chick MyoD clone by Lin et al. (Lin et al., 1989).
Chick embryology
Fertilized Ross White chicken eggs were supplied by Henry Steward & Co.
Ltd (Lincolnshire, UK) and were incubated at 37±1°C. Embryos were staged
according to Hamburger and Hamilton (Hamburger and Hamilton, 1951).
Stage 20/21 mandibular primordia micromass cultures were prepared as
described (Anakwe et al., 2003) and were plated in the presence of high titer
RCASBP viruses encoding an activated version of Pitx2 or a dominant-
negative Pitx2 construct (Yu et al., 2001). Micromasses were cultured for 3
days, fixed briefly in ice-cold methanol and immunostained with the pan-
myosin antibody, A4.1025 (1 in 100), and A4.840 (1 in 50), which
recognizes cells expressing the slow MyHC isoforms SM3 and SM1 (from
the Developmental Studies Hybridoma Bank). This was followed by
incubation with horse anti-mouse IgG (-specific) conjugated to FITC
(Vector; 1:400) and donkey anti-mouse IgM (-specific) conjugated to Cy3
(Jackson; 1:800) for at least 1 hour at room temperature. Following three
PBS washes for 5 minutes, cultures were mounted under coverslips with
PBS:glycerol (1:9) with 0.1% phenylenediamine as an antifade reagent.
Values shown are the mean and standard error of the mean of at least nine
cultures from three independent experiments. The data was analysed using
Student’s t-test.
Histology and apoptosis
For histology, embryos were fixed overnight in Bouin’s fixative or buffered
formalin, dehydrated through graded ethanol and embedded in paraffin.
Sections were cut at 7-10 m and stained with H&E. For TUNEL, embryos
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Fig. 1. Pitx2 is required for survival of branchiomeric muscle
precursors. (A,B) Right and left views of 9.5 dpc mouse embryos after
whole-mount in situ hybridization with a Pitx2 probe (arrows denote
hybridization signal). (C-H) Expression in chick embryos of Pitx2
(C,E,F,H) and MyoD (D,G) analysed by whole-mount in situ
hybridization (C,F) and radioactive in situ hybridization to tissue sections
(D,E,G,H) of stage 10 (C,F), 24 (D,E) and 26 (G,H) chick embryos. C is a
dorsal view and D,E,G,H are frontal sections through the facial
primordial. F is a transverse vibratome section through the head of the
embryo in C. Arrows in D,G indicate developing muscles, in E the
ectodermal and mesodermal expression of Pitx2, in H the
ectomesenchymal Pitx2 expression. do, dorsal oblique muscle; e, eye; f,
frontonasal mass; hy, hyoid arch; md, mandibular primordia.
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were first stained for LacZ using the whole-mount protocol, then embedded
in paraffin and sectioned. TUNEL staining was performed according to the
manufacturer’s protocol (Serologicals Corporation).
RESULTS
Pitx2 expression in branchial arch mesoderm is
conserved between mouse and chick
We evaluated Pitx2 expression in mouse and chick embryos. At 8.5
days post coitum (dpc) in the mouse, Pitx2 was expressed in oral
ectoderm and head mesoderm (Mitsiadis et al., 1998; Mucchielli et
al., 1997). At 9.5 dpc, Pitx2 was expressed in mesoderm-derived,
core cells of the first branchial arch (Fig. 1A,B) (Mucchielli et al.,
1997). In chick embryos, Pitx2 was expressed in head mesoderm
(Fig. 1C,F) and in the core mesoderm of the branchial arch (Fig.
1D,E). More dorsal sections indicated that Pitx2 was also expressed
in periocular mesenchyme and extraocular muscles (Fig. 1G,H). As
in the mouse, Pitx2 was also expressed in oral ectoderm (Fig. 1E).
Pitx2 expression colocalized with the muscle marker MyoD in
branchial arch mesoderm and extraocular muscle (Fig. 1D,E,G,H).
Taken together, these findings suggest that the function of Pitx2 in
branchiomeric muscle is probably conserved between mouse and
chick.
Pitx2 function is required for MyoR but not Tbx1
expression in ﬁrst branchial arch muscle
precursors
We next looked at markers of muscle development in Pitx2null and
Pitx2 hypomorphic mutant embryos. myogenin encodes one of the
four bHLH MRFs and is required for muscle development (Hasty et
al., 1993). Moreover, myogenin is a late muscle marker that is
important for muscle differentiation. In Pitx2 control embryos,
myogenin was highly expressed in the branchial arch core cells,
while in Pitx2 hypomorphic embryos, myogenin was greatly
reduced (Fig. 2A,B). Importantly, in Pitx2null–/– embryos myogenin
was absent, indicating that muscle precursors in the branchial arch
core fail to activate myogenin, an essential regulator of muscle
differentiation (Fig. 2C). MyoD is another MRF and is a marker of
committed myoblasts. Similar to myogenin, we found that MyoD
expression was absent in the Pitx2null mutant embryos, indicating
that myoblasts failed to be specified in the first branchial arch of
Pitx2null mutants (Fig. 2D,E). It is also possible that defects in
myogenin and MyoD expression result from a loss of progenitor
cells (see below).
Previous studies have identified a requirement for the bHLH
transcription factors MyoR and capsulin in development of first
branchial arch muscle (Lu et al., 2002). In addition, MyoR marks
undifferentiated muscle precursor cells (von Scheven et al., 2006b).
Moreover, in the MyoR; capsulin double-mutant embryos, elevated
apoptosis was detected in the core branchial arch cells. In Pitx2null
mutant embryos, MyoR failed to be expressed in the core cells of the
first branchial arch (Fig. 2F,G). Previous work has also established
that the T-box transcription factor Tbx1 is expressed in core cells of
the branchial arches and is required for first branchial arch muscle
development, although MyoR continues to be expressed in the Tbx1
mutants (Kelly et al., 2004). In Pitx2null mutants, Tbx1 was still
expressed in the first branchial arch, although in a reduced
expression domain (Fig. 2H,I). In addition, expression of Pitx2 in
Tbx1 null mutants was also unaffected (Fig. 2J,K). Taken together,
these findings indicate a defect in undifferentiated muscle
progenitors in Pitx2 mutant embryos.
Committed myoblasts are absent in the Pitx2 null
mutant ﬁrst branchial arch
The expression analysis suggested that specification of myoblasts
was defective in Pitx2null mutant embryos. To study this question
in more detail, we performed lineage tracing with a Myf5cre allele
that marks cells that have activated expression of Myf5 in
committed myoblasts (Tallquist and Soriano, 2003). This is
a very sensitive method for following the developmental
progression of Myf5-expressing descendents. Induction of
recombination at the Rosa 26 reporter locus by cre recombinase
is heritable and irreversible and so is a reliable method for
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Fig. 2. Defective
speciﬁcation of ﬁrst
branchial arch
undifferentiated core
mesoderm in Pitx2 mutants.
(A-C) Myogenin and (D,E)
MyoD fail to be expressed
normally in Pitx2 mutant
embryos. (F-I). MyoR, a marker
of undifferentiated core
mesoderm, fails to be
expressed in the Pitx2null
mutant embryos while another
marker of undifferentiated
progenitors. (J,K) Pitx2
expression in control and
Tbx1null mutant embryos.
Arrows denote ﬁrst branchial
arch hybridization signal or
absence of signal. Arrowheads
in F,G denote signal in the
second branchial arch.
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performing lineage tracing in mouse embryos (Soriano, 1999).
Myf5 expression is activated in the branchial arches at
approximately 9.25 dpc. In Pitx2null mutants, the number of LacZ-
marked Myf5 descendents was drastically reduced in the first
branchial arch, consistent with the expression data indicating that
myoblast specification in core cells of the first branchial arch was
defective (Fig. 3A,B).
At 10.5 dpc, Myf5cre marked cells were present both within the
branchial arch and dorsal to the first branchial arch in control
embryos. The dorsal cells probably represent myoblasts that are
migrating from the cranial paraxial mesoderm (Tirosh-Finkel et al.,
2006; Trainor et al., 1994). In Pitx2null mutants, Myf5cre-marked
cells were excluded from the first branchial arch but were still
present in the dorsally located migrating myoblasts (Fig. 3C,D).
By 11.5 dpc, Myf5cre-marked cells had started to form the masseter
muscle mass spanning the maxilla and mandible. In the Pitx2null
embryos, a small group of Myf5cre-marked cells was apparent,
indicating that a reduced number of cells in the mandibular process
activated Myf5 expression (Fig. 3E,F). It is also notable that
Myf5cre-marked cells, contributing to extraocular muscles, were
present but failed to localize properly around the developing eye
(Fig. 3D,F). Taken together, these findings indicate that specified
branchiomeric myoblasts are drastically reduced in Pitx2null
mutant embryos. We interpret these data to indicate a defect in
muscle specification, although it should be noted that defective
migration or a developmental delay may also contribute to the
phenotype.
Pitx2 descendents move into the ﬁrst branchial
arch but fail to form mature muscle
We performed a lineage-tracing experiment with the Wnt1cre
transgenic line that directs cre activity in the neural crest that
surrounds, and therefore outlines, the mesoderm in the branchial
arch (Chai et al., 2000). In control embryos, LacZ-negative
mesoderm-derived cells were outlined by blue, neural crest
derivatives (Fig. 4A). In the Pitx2null mutant embryo, there was a
reduction in the number of mesoderm cells; however, core
mesoderm was present in the Pitx2null mutant (Fig. 4A,B).
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Fig. 3. Speciﬁed, Myf5-positive myoblasts are drastically reduced
in the Pitx2null mutant branchial arch. (A,B) Lineage tracing with the
Myf5cre allele indicates that the Myf5 lineage is drastically reduced in
the ﬁrst branchial arch of 9.5 dpc Pitx2null mutant embryos (arrows).
(C,D) By 10.5 dpc, the Myf5 lineage has expanded in the wild-type ﬁrst
branchial arch (arrow in C) but is still greatly reduced in the Pitx2null
branchial arch. LacZ-positive cells are detectable dorsal to the branchial
arch in both control and Pitx2null embryos (arrow in D). Also the Myf5
lineage that contributes to extraocular muscle is mislocalized in Pitx2null
embryos (arrowhead in D). (E,F) In the 11.5 dpc embryo, a small
number of Myf5cre-labeled cells can be detected, indicating that a few
speciﬁed myoblasts are present in the Pitx2null mutant branchial arch
(arrow in E,F). Abnormal localization of the EOM precursors is still
observed in the Pitx2null embryo (arrowhead in F). e, eye; fn, frontonasal
mass; md, mandible; mx, maxilla; ov, otic vesicle.
Fig. 4. Fate mapping Pitx2 descendants in Pitx2 mutant embryos.
(A,B) Lineage tracing with the Wnt1cre transgenic line that outlines core
mesoderm of the ﬁrst branchial arch. (C,D) Lineage tracing with the
Pitx2cre allele showing Pitx2 lineage contributes to the core mesoderm
in both control (arrow in C) and Pitx2null embryos (arrow in D).
(E,F) Lineage tracing with the Pitx2cre allele in control (E) and Pitx2
hypomorphic embryos (F) at 16.5 doc. Pitx2 descendents contribute to
branchiomeric muscle in the control, but in the mutant branchiomeric
muscle is absent (arrow). (G,H) Lineage tracing and TUNEL double-
labeling in control and Pitx2null mutant embryos. The LacZ-positive cells
are Pitx2 descendents that show upregulated TUNEL-positive cells in the
mutant (arrow). mo, molar tooth; to, tongue.
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To establish more firmly that Pitx2 descendents were present in
the first branchial arch of Pitx2 mutant embryos, we used the Pitx2cre
allele to mark Pitx2 descendents (Liu et al., 2002). This strategy also
marks cells that are fated to express Pitx2. In control
Pitx2creneo;R26R embryos, we found that Pitx2 descendents
contributed to the core mesoderm of the first branchial arch (Fig.
4C). In Pitx2null embryos, Pitx2 descendents were still present in the
first branchial arch core, although in reduced numbers (Fig. 4D).
We next examined embryos at 16.5 dpc to evaluate if first
branchial arch muscle was defective in Pitx2 mutants. Because
Pitx2null homozygous mutant embryos are lethal at 14.0 dpc, we
used a weak hypomorphic allele of Pitx2, referred to as the Pitx2hypo
allele for this experiment (see Materials and methods for allele
description). In control embryos, LacZ-marked Pitx2 descendents
were observed in the masseter muscle, as well as oral and dental
epithelium (Fig. 4E). In the Pitx2 hypomorphic mutant, both LacZ-
marked Pitx2 descendents and first branchial arch muscle were
absent (Fig. 4F).
To investigate the possibility that in Pitx2 mutants, the core
mesoderm cells of the branchial arch underwent apoptosis, we
performed TUNEL analysis on embryos in which the Pitx2 lineage
was LacZ-marked.
In agreement with previous observations, control core mesoderm
had little cell death (Fig. 4G) (Lu et al., 2002). By contrast, in
Pitx2null embryos, LacZ-marked Pitx2 mutant descendents were
TUNEL-positive, indicating that Pitx2null cells were undergoing cell
death (Fig. 4G,H). Together these data indicate that Pitx2 is required
for development of the first branchial arch muscle. Moreover, Pitx2
mutant descendents are present in the branchial arch at 11.5 dpc, but
they undergo apoptosis and are gone by 16.5 dpc.
Pitx2 is required for splanchnic mesoderm to
contribute to branchiomeric muscle
Previous work revealed that a Mef2c enhancer element specifically
directed LacZ expression in splanchnic mesoderm that contributed
to the cardiac OFT but was not expressed in branchiomeric muscle
(Dodou et al., 2004). Subsequent experiments using this Mef2c
enhancer to direct cre activity indicated that descendents of
the Mef2c-expressing splanchnic mesoderm contributed to
branchiomeric muscle (Fig. 5A,B) (Verzi et al., 2005). Thus, the
Mef2c AHF cre provides a valuable reagent to dissect the role of
splanchnic mesoderm in branchiomeric muscle.
We used the Mef2c AHF cre to trace the splanchnic mesoderm
lineage in Pitx2null mutant embryos. At 9.5 dpc, Mef2c AHF
descendents were drastically reduced in the Pitx2null mutant embryos
(Fig. 5C,D). One day later, at 10.5 dpc, a few LacZ-positive cells
were visible in the first branchial arch of Pitx2null mutant embryos
(Fig. 5E,F). At 11.5 dpc, Mef2c AHF descendents were no longer
detectable in the Pitx2null mutant embryos. At this late stage, we
noted an abnormal dispersion of Mef2c AHF cre descendents in the
caudal branchial arches (Fig. 5G,H). The significance of this is
unclear and is currently under investigation. Together, these data
reveal a defect in development of the splanchnic mesoderm
component of branchiomeric muscle in Pitx2null mutant embryos.
Pitx2 autonomously promotes muscle expansion
Because Pitx2 regulates Fgf8 and Bmp4-signaling pathways in
branchial arch morphogenesis, we wanted to investigate the cell-
autonomous role of Pitx2 in branchiomeric muscle (Lu et al., 1999).
We turned to the chick embryo system because of its utility as an
experimental system. Furthermore, Pitx2 expression is highly
conserved between mice and chicks (Fig. 1) and Pitx2 is expressed
in the early chick cranial mesoderm before any onset of myogenesis
(Fig. 1C,F). Then at later stages of development, Pitx2 transcripts
are found in all the cranial muscles derived from the unsegmented
cranial mesoderm – i.e. those found in the mandibular and hyoid
arch and the extraocular muscles (Fig. 1D,E,G,H).
Muscle precursor cells, including the surrounding
ectomesenchyme but not the ectoderm, were isolated from the
developing mandible and infected with a retrovirus expressing
Pitx2a. This resulted in a statistically significant elevation in the
number of myosin-positive cells when compared with control cells
(Fig. 6A,B). We next used a retrovirus expressing a dominant-
negative form of Pitx2a to decrease Pitx2 activity in muscle
precursors. Primary cultures with reduced Pitx2a activity had lower
numbers of myosin-positive cells, which was a statistically
significant difference from the control (Fig. 6A,B). We also assessed
whether Pitx2a had a differential effect on slow versus fast myocyte
differentiation by immunostaining with a slow MyHC antibody
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Fig. 5. Splanchnic mesoderm-derived Mef2cAHFcre-marked
muscle precursors are reduced in the Pitx2null mutant branchial
arch. (A,B) Lineage tracing with the Mef2c AHF cre transgenic driver
and the R26R allele indicated that the Mef2c-marked splanchnic
mesoderm lineage contributes to ﬁrst branchial arch branchiomeric
muscle (denoted by arrows). (C-H) Lineage tracing with the Mef2c AHF
cre in the control and Pitx2null mutant embryos indicated a deﬁciency in
the splanchnic mesoderm component of the ﬁrst branchial arch muscle
precursors (denoted by arrows) in Pitx2null mutant embryos at 9.5 dpc
(C,D), 10.5 dpc (E,F) and 11.5 dpc (E,F). It is notable that in the 11.5
dpc Pitx2 mutant embryo, Mef2c AHF cre-marked cells are found
diffusely scattered in the caudal branchial arches (arrowhead). e, eye;
md, mandibular process; mx, maxillary process.
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(Hughes and Blau, 1992). This showed that loss and gain of Pitx2a
function affected the development of both slow and fast myocytes
(Fig. 6B). These data indicate that Pitx2a is necessary and sufficient
for myocyte development in the context of craniofacial
mesenchyme.
Conditional inactivation revealed a cell-
autonomous function for Pitx2 in branchiomeric
muscle precursors
We used the Mesp1cre knock-in and Pitx2flox alleles to inactivate
Pitx2 specifically in mesoderm-derived cells. As Pitx2 is expressed
in oral ectoderm in the first branchial arch, Pitx2 inactivation in
mesoderm will leave the Pitx2 ectoderm expression domain intact
while removing Pitx2 from branchiomeric muscle precursors. The
Mesp1cre allele directs cre activity broadly in mesoderm before
muscle differentiation (Saga et al., 1999; Zhang et al., 2006).
Lineage tracing with the Mesp1cre and R26R alleles revealed that
the Mesp1-expressing lineage contributed efficiently to masseter
muscle in the control (Fig. 7A). By contrast, in Pitx2 conditional
mutants (Mesp1cre; Pitx2flox/null (f/n)) there was a deficiency in masseter
development (Fig. 7B). Investigation of myogenin expression in the
Mesp1cre; Pitx2f/n embryos also indicated that branchiomeric muscle
was defective in Pitx2 conditional mutants (Fig. 7C,D). Sections with
H&E staining (Fig. 7E-H) and immunohistochemistry with a muscle-
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Fig. 6. Elevated and reduced Pitx2 activity in chick
primary myoblasts. (A) Fluorescent images of mandibular
micromass cultures, which have been infected with a
control, Pitx2a or Pitx2a RCASBP retrovirus showing
myocytes that have been visualized with the pan MyHc
antibody A4.1025. (B) Bar chart quantifying these effects
and also showing the effect on slow (red bar) and fast
(yellow bar) myocyte development. *P<0.05.
Fig. 7. Conditional ablation of
Pitx2 in mesoderm-derived cells
reveals an autonomous role for
Pitx2 in branchiomeric muscle
development. Pitx2 deletion in
mesoderm using the Mesp1cre and
Pitx2flox alleles. (A,B) Lineage tracing
indicates a reduction in the number
of LacZ-marked Pitx2 mutant
descendents in the masseter muscle
(outlined, arrow). (C,D) Myogenin
expression (arrow) is greatly reduced
in the Pitx2 mutant compared with
control. Sections through the
masseter muscle of control (E,F) and
Mesp1cre; Pitx2 n/f mutant (G,H)
indicate a muscle deﬁciency in the
Pitx2 conditional mutant (arrows).
(I-L) Myosin immunostaining with
the MF20 antibody in 14.5 control
(I,J) and Pitx2 conditional null
mutant (K,L) to mark branchiomeric
muscle in control and show
deﬁciency in mutant (arrows). Note
that in the mutant (L) there is
residual subcutaneous muscle that
shows myosin reactivity
(arrowhead). e, eye; mc, Meckel’s
cartilage; md, mandible; mx, maxilla.
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specific myosin antibody of control and Mesp1cre; Pitx2f/n embryos
also indicated that branchiomeric muscle was severely defective in
Pitx2 mutants (Fig. 7I-L).
We next used the Mef2cAHFcre, which directs cre activity in the
splanchnic mesoderm beginning at stages before branchiomeric
muscle development (Dodou et al., 2004; Verzi et al., 2005), to
conditionally ablate Pitx2 in the splanchnic mesoderm component
of branchiomeric muscle. We have recently shown that conditional
deletion of Pitx2 with Mef2c AHFcre resulted in severe cardiac
defects (Ai et al., 2006). We used lineage tracing with R26R to
follow the progression of branchiomeric muscle progenitors in the
control and Pitx2 conditional mutant embryos. At 9.5 dpc, the Mef2c
AHF lineage was clearly marked in the core cells of the first
branchial arch, while in the Pitx2 conditional mutant there was a
deficiency in LacZ-marked cells (Fig. 8A,B). Similarly, for 11.5 and
12.0 dpc embryos, we consistently found a deficiency in the LacZ-
marked Mef2c AHF lineage in the Pitx2 conditional mutants (Fig.
8C-F). It is notable that in all embryos examined, we found a small
contribution of LacZ-marked cells in the Pitx2 conditional mutant
embryos. This observation suggests that the Mef2c AHF cre failed
to completely inactivate Pitx2 in branchiomeric muscle progenitors.
It is also possible that there is a subpopulation of muscle precursors
that are Pitx2 independent. Nonetheless, taken together with the
Mesp1cre data, our findings indicate that Pitx2 has an autonomous
function in the development of branchiomeric muscle progenitors.
DISCUSSION
The findings presented here uncover a requirement for Pitx2 in
branchiomeric muscle development and provide insight into the
genetic pathways controlling development of branchiomeric muscle.
In Pitx2null embryos, branchiomeric muscle precursors were initially
present but failed to expand and activate the myogenic program.
Moreover, lack of MyoR expression and elevated apoptosis indicated
a defect in survival of undifferentiated muscle progenitor cells.
Conditional Pitx2 inactivation and overexpression and knockdown
in chick primary cultures supported a direct role for Pitx2 in
branchiomeric muscle development. In addition, we showed that
Pitx2 has a function in the splanchnic mesoderm-derived component
of branchiomeric muscle.
Pitx2 function in muscle
Pitx2 is expressed in multiple muscle types, including extraocular
muscle, branchiomeric muscle, cardiac muscle and trunk skeletal
muscle (Ai et al., 2006; Kitamura et al., 1999). The in vivo function
of Pitx2 in trunk skeletal muscle is poorly understood. Previous
experiments investigating Pitx2 in the C2C12 myoblast cell line,
derived from satellite cells of the adult leg, uncovered a direct role
for Pitx2 in regulating myoblast proliferation through a mechanism
mediated by the N-terminus of Pitx2a (Kioussi et al., 2002). In the
heart, Pitx2 regulates proliferation of cardiomyocytes of the OFT
(Ai et al., 2006). In extraocular muscle, it has been suggested that
Pitx2 may directly regulate MRF transcription (Diehl et al., 2006).
Our data indicate that, in branchiomeric muscle, Pitx2 regulates
undifferentiated precursor cells and probably controls expression of
genes that are involved in muscle expansion and survival. Recent
experiments revealed a role for MyoR and capsulin in the survival of
a subset of first branchial muscle precursors (Lu et al., 2002). The
Pitx2null mutant branchiomeric muscle precursors fail to express
MyoR and undergo apoptosis. It is notable that there is evidence in
the pituitary that Pitx2 and the related factor Pitx1 promote cell
survival by regulating expression of Lhx3 (Charles et al., 2005; Zhao
et al., 2006). In addition, the third member of the Pitx family, Pitx3,
is required for postnatal survival of midbrain dopaminergic neurons
(van den Munckhof et al., 2003). The requirement for Pitx2 in
undifferentiated precursor cells contrasts with the function of
Pitx2 in asymmetric organ morphogenesis. In left right organ
morphogenesis, Pitx2 activity is needed in the organ primordium
rather than in undifferentiated precursors (Ai et al., 2006; Shiratori
et al., 2006). This may reflect a difference in tissues that only express
Pitx2c.
Pitx2 and Tbx1 in craniofacial muscle
development
Tbx1 mutants have sporadic failure of craniofacial muscle
development with loss of Tlx1 and Fgf10 expression (Kelly et al.,
2004). Moreover, Tbx1 has been suggested to directly activate
Pitx2 in the second cardiac lineage by binding to an element
upstream of exon 6 (Nowotschin et al., 2006). Tbx1 was still
expressed in undifferentiated cells of the Pitx2null mutant branchial
arch core mesoderm consistent with the notion that Tbx1 is an
upstream regulator of Pitx2. However, Pitx2 was still expressed in
Tbx1null mutants, indicating that a simple epistatic relationship is
unlikely. In addition, by contrast to Pitx2null mutant embryos, Tbx1
mutants continue to express MyoR in the branchiomeric
progenitors, further arguing against a linear, epistatic relationship
(Kelly et al., 2004).
Alternatively, it may be that Pitx2 and Tbx1 regulate parallel
pathways that may converge on common target genes. Pitx and Tbx
genes have been shown to coordinately regulate gene expression in
the pituitary. Pitx1 and Tpit (Tbx19) bind to proximate but distinct
recognition elements in the POMC promoter (Lamolet et al., 2001).
In this system, Pitx1 synergized with Tbx19 but failed to
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Fig. 8. Ablation of Pitx2 in
splanchnic mesoderm with
Mef2cAHFcre– reveals an
autonomous role for Pitx2 in
branchiomeric muscle
development. (A-F) Lineage tracing
with the Mef2c AHF cre transgenic
driver (arrows) indicated that the
Mef2c-marked splanchnic mesoderm
lineage is reduced in the ﬁrst
branchial arch of Mef2c AHF cre; Pitx2
n/f conditional mutant embryos at 9.5
dpc (A,B), 11.5 dpc (C,D) and 12.0
dpc (E,F). e, eye; md, mandibular
process; mx, maxillary process.
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transcriptionally synergize with Tbx1, suggesting that cell-type-
specific co-factors may be required for any potential synergism
between Pitx2 and Tbx1 in branchiomeric muscle progenitors
(Lamolet et al., 2001). It is notable that in the zebrafish mutant van
gogh, which carries a mutant allele of Tbx1, muscle expression of
endothelin 1 (edn1) is reduced (Piotrowski et al., 2003). In Pitx2null
mutants, edn1 expression is reduced in the oral ectoderm, suggesting
the possibility that the Tbx1 and Pitx2-mediated pathway may
converge on edn1 (Liu et al., 2003). Further experiments will be
required to investigate this idea.
Splanchnic mesoderm contribution to
branchiomeric muscle
Similar to that described for the cardiac OFT, multiple lineages with
distinct developmental histories contribute to branchiomeric muscle.
In the heart, the primary heart field contributes to the linear heart
tube, while the second lineage is sequestered and moves into the
OFT at a later stage. The later addition of the secondary heart field
is required for proper OFT lengthening and morphogenesis
(Buckingham et al., 2005). In branchiomeric muscle, the addition of
cells from multiple lineages may play a similar role in controlling
the size and pattern of craniofacial muscle.
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